APPROACHES TOWARD COMBINING PHOTODYNAMIC THERAPY WITH PHARMACEUTICALS THAT ALTER VASCULAR MICROENVIRONMENT

被引:8
作者
Busch, Theresa [1 ]
机构
[1] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2009年 / 29卷 / 06期
关键词
photodynamic therapy; vascular endothelial growth factor; verteporfin;
D O I
10.1097/IAE.0b013e3181ad25e8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Photodynamic therapy has been widely replaced by antiangiogenesis agents for the first-line therapy for exudative age-related macular degeneration (AMD). There is a strong basis for predicting that a combination of photodynamic therapy and antiangiogenesis agents may address the relative disadvantages of each. By improving the rates of response, photodynamic therapy has the potential to reduce the frequency with which intravitreal injections of antiangiogenesis agents are required. Antiangiogenesis agents may augment the activity of photodynamic therapy by inhibiting its counterproductive upregulation of vascular endothelial growth factor. Clinical studies of this combination are being advanced in both AMD and in the treatment of malignancies. RETINA 29:S36-S38, 2009
引用
收藏
页码:S36 / S38
页数:3
相关论文
共 8 条
[1]   Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): Year 2 results [J].
Antoszyk, Andrew N. ;
Tuomi, Lisa ;
Chung, Carol Y. ;
Singh, Angele .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (05) :862-874
[2]   Hypericin-mediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins [J].
Bhuvaneswari, Ramaswamy ;
Yuen, Gan Yik ;
Chee, Soo Khee ;
Olivo, Malini .
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES, 2007, 6 (12) :1275-1283
[3]   Photoreceptor Protection after Photodynamic Therapy Using Dexamethasone in a Rat Model of Choroidal Neovascularization [J].
She, Haicheng ;
Nakazawa, Toru ;
Matsubara, Akihisa ;
Connolly, Edward ;
Hisatomi, Toshio ;
Noda, Kousuke ;
Kim, Ivana ;
Gragoudas, Evangelos S. ;
Miller, Joan W. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (11) :5008-5014
[4]   Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration [J].
Smith, Bradley T. ;
Dhalla, Mandeep S. ;
Shah, Gaurav K. ;
Blinder, Kevin J. ;
Ryan, Edwin H. ;
Mittra, Robert A. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (05) :675-681
[5]  
TARTAR O, 2006, AM J OPHTHALMOL, V142, P95
[6]   Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization [J].
Tatar, Olcay ;
Shinoda, Kei ;
Kaiserling, Edwin ;
Pertile, Grazia ;
Eckardt, Claus ;
Mohr, Andreas ;
Yoeruek, Efdal ;
Szurman, Peter ;
Bartz-Schmidt, Karl U. ;
Grisanti, Salvatore .
ARCHIVES OF OPHTHALMOLOGY, 2008, 126 (02) :193-199
[7]   Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes [J].
Tatar, Olcay ;
Kaiserling, Edwin ;
Adam, Annemarie ;
Gelisken, Faik ;
Shinoda, Kei ;
Völker, Michael ;
Lafaut, Bart A. ;
Bartz-Schmidt, Karl Ulrich ;
Grisanti, Salvatore .
ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (06) :815-823
[8]   Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metal loproteinases [J].
Winkler, F ;
Kozin, SV ;
Tong, RT ;
Chae, SS ;
Booth, MF ;
Garkavtsev, I ;
Xu, L ;
Hicklin, DJ ;
Fukumura, D ;
di Tomaso, E ;
Munn, LL ;
Jain, RK .
CANCER CELL, 2004, 6 (06) :553-563